Prognostic indicators in well-differentiated XXXX when controlling for stage and treatment.

@entity1 @entity259 @entity204 @entity5
OBJECTIVES/HYPOTHESIS: The incidence of @entity259 is rising. Few studies have examined @entity1 characteristics that influence survival when adjusting for treatment and @entity5 stage/extent. STUDY DESIGN: Retrospective analysis was performed using the Surveillance Epidemiology and End Results registry data among @entity1 diagnosed with well-differentiated @entity259 during 1988-2009. METHODS: Kaplan-Meir survival curves were used to estimate 5- and 10-year cause-specific and overall survival differences by sociodemographics, clinical characteristics, and treatment. Multivariate Cox proportional hazard models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). RESULTS: A total of 83,985 @entity1 were identified with @entity259 . Blacks had higher hazard of @entity204 at 5 years (HR, 1.67; 95% CI, 1.42-1.96) and 10 years (HR, 1.57; 95% CI, 1.37-1.80) when compared to Caucasians, but there were no significant differences in cause-specific deaths. Hispanics had higher overall and cause-specific 5-year and 10-year hazard of @entity204 (5-year cause-specific: HR, 1.56; 95% CI, 1.23-1.99). Age was the most significant predictor of cause-specific and overall survival, with risk increasing in a nonlinear fashion. After age 45 years, the HR for 5- and 10-year cause-specific survival rose drastically, reaching an HR of 153 for individuals aged 85 years and older (HR, 153.45; 95% CI, 97.84-240.67). CONCLUSIONS: Age was the strongest factor associated with WDT @entity5 in our study. African Americans had worse overall survival, although only Hispanics had a significantly worse cause-specific survival. These factors should be taken into account in counseling @entity1 and treatment planning. LEVEL OF EVIDENCE: 2c. Laryngoscope, 2014.
